Name: Retatrutide Guide
Creator: Peppa
Published: 2025-01-15

Retatrutide — Benefits, Dosing & Protocol GuideA revolutionary triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously for unprecedented weight loss results. Eli Lilly's next-generation obesity medication showing up to 24% weight loss in trials. Represents the cutting edge of metabolic peptide therapy.Key Benefits

Exceptional weight loss (up to 24% in trials)

Reduces appetite significantly

Improves metabolic health markers

Lowers cardiovascular risk factors

May reverse fatty liver disease

Applications: Weight Loss, Metabolism Support, Cardiovascular, Anti-InflammatoryWritten by Peppa at Peptide Upside — the peptide lifestyle guide. Research, calculate, and track your peptide journey.